Masimo Corporation (MASI)Healthcare | Medical Devices | Irvine, United States |
USD
|
Hot Take ↕ | July 11, 2026, 9:22 a.m. UTC
The immediate outlook is overwhelmingly bullish due to the definitive acquisition by Danaher at $180 per share, which effectively caps the upside while eliminating downside risk for existing holders. The stock recently surged 34% as the deal was announced, trading right at the offer price, suggesting the market has fully priced in the transaction. However, this is a classic 'sell the news' scenario; since the deal is completed and the company is delisting from Nasdaq, the speculative momentum that drove the recent rally will likely dissipate, leaving the stock to trade at the acquisition price until the final settlement. From a long-term perspective, there is no investment thesis because the entity is exiting the public markets, rendering any analysis of its future revenue growth or competitive moat irrelevant for equity investors. Furthermore, the security offers no income component, as there is no history of dividend payments, making it unsuitable for income-focused strategies. The only rational action for a public market participant is to consider taking profits now that the certainty of the exit price has been established. |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2012-11-23 |
| Last Dividend Date | 2012-11-23 |
| Debt to Equity Ratio | 61.592 |
| Revenue per Share | 29.323 |
| Market Cap | 9,423,817,728 |
| Trailing P/E | 44.43 |
| Forward P/E | 26.87 |
| Beta | 1.10 |
| Profit Margins | 4.90% |
| Website | https://www.masimo.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.10554767 |
| Address1 | 52 Discovery |
| All Time High | 305.21 |
| All Time Low | 17.62 |
| Ask | 194.36 |
| Ask Size | 100 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 854,373 |
| Average Volume | 946,426 |
| Average Volume10Days | 854,373 |
| Beta | 1.098 |
| Bid | 165.59 |
| Bid Size | 100 |
| Board Risk | 2 |
| Book Value | 15.065 |
| City | Irvine |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Currency | USD |
| Current Price | 179.95 |
| Current Ratio | 2.675 |
| Date Short Interest | 1,780,012,800 |
| Day High | 179.99 |
| Day Low | 179.95 |
| Debt To Equity | 61.592 |
| Ebitda | 367,700,000 |
| Ebitda Margins | 0.23593001 |
| Enterprise To Ebitda | 26.61 |
| Enterprise To Revenue | 6.278 |
| Enterprise Value | 9,784,526,848 |
| Ex Dividend Date | 1,353,628,800 |
| Exchange | NGM |
| Exchange Timezone Name | UTC |
| Fax | 949 297 7001 |
| Fifty Day Average | 178.6867 |
| Fifty Two Week High | 179.99 |
| Fifty Two Week Low | 125.94 |
| Financial Currency | USD |
| First Trade Date Epoch Utc | 1,781,098,200 |
| Float Shares | 44,306,186 |
| Forward Eps | 6.705 |
| Forward P E | 26.871563 |
| Free Cashflow | 327,924,992 |
| Full Time Employees | 2,200 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,780,531,200 |
| Gross Margins | 0.6163 |
| Gross Profits | 960,499,968 |
| Held Percent Insiders | 0.06215 |
| Held Percent Institutions | 1.04782 |
| Implied Shares Outstanding | 52,369,086 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Last Dividend Date | 1,353,628,800 |
| Last Dividend Value | 1.0 |
| Last Fiscal Year End | 1,767,398,400 |
| Long Business Summary | Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California. |
| Long Name | Masimo Corporation |
| Market Cap | 9,423,817,728 |
| Max Age | 86,400 |
| Message Board Id | finmb_31167 |
| Most Recent Quarter | 1,775,260,800 |
| Net Income To Common | 216,800,000 |
| Next Fiscal Year End | 1,798,934,400 |
| Non Diluted Market Cap | 9,423,817,025 |
| Number Of Analyst Opinions | 3 |
| Open | 179.95 |
| Operating Cashflow | 232,000,000 |
| Operating Margins | 0.23612 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Peg Ratio | 4.83 |
| Phone | 949 297 7000 |
| Previous Close | 0.0 |
| Price Hint | 2 |
| Price To Book | 11.944905 |
| Price To Sales Trailing12 Months | 6.046723 |
| Profit Margins | 0.04896 |
| Quick Ratio | 1.271 |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Regular Market Day High | 179.99 |
| Regular Market Day Low | 179.95 |
| Regular Market Open | 179.95 |
| Regular Market Previous Close | 0.0 |
| Regular Market Volume | 3,089,485 |
| Return On Assets | 0.10198 |
| Return On Equity | 0.24987 |
| Revenue Growth | 0.085 |
| Revenue Per Share | 29.323 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 52,369,086 |
| Shares Percent Shares Out | 0.0669 |
| Shares Short | 3,501,739 |
| Shares Short Previous Month Date | 1,777,507,200 |
| Shares Short Prior Month | 3,884,472 |
| Short Name | Masimo Corporation |
| Short Percent Of Float | 0.0734 |
| Short Ratio | 3.84 |
| State | CA |
| Symbol | MASI |
| Target High Price | 180.0 |
| Target Low Price | 180.0 |
| Target Mean Price | 180.0 |
| Target Median Price | 180.0 |
| Time Zone Full Name | America/New_York |
| Time Zone Short Name | EDT |
| Total Cash | 124,600,000 |
| Total Cash Per Share | 2.379 |
| Total Debt | 485,900,000 |
| Total Revenue | 1,558,499,968 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Eps | 4.05 |
| Trailing P E | 44.432095 |
| Trailing Peg Ratio | None |
| Two Hundred Day Average | 156.65875 |
| Underlying Symbol | MASI |
| Uuid | e632c796-2b7c-370d-8fe5-85eca27f2bf0 |
| Volume | 3,089,485 |
| Website | https://www.masimo.com |
| Zip | 92,618 |